Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study
Status: | Completed |
---|---|
Conditions: | Diabetes |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 10/14/2017 |
Start Date: | June 2006 |
End Date: | October 2007 |
The purpose of this study is to evaluate the effectiveness of automated telephone outreach
with speech recognition to improve diabetes care.
with speech recognition to improve diabetes care.
Randomly allocate a total of 1200 health plan members with diabetes to automated telephone
outreach with speech recognition (ATO-SR; N = 600) or usual care (N = 600). The intervention
is a series of three calls, using automated calls, originating from the health plan, using
interactive speech recognition technology, spaced approximately 4-6 weeks apart, to encourage
participants to fulfill the recommended testing (dilated eye examinations, glycated
hemoglobin, LDL-cholesterol, microalbumin) that had not been performed received in the
preceding year.
outreach with speech recognition (ATO-SR; N = 600) or usual care (N = 600). The intervention
is a series of three calls, using automated calls, originating from the health plan, using
interactive speech recognition technology, spaced approximately 4-6 weeks apart, to encourage
participants to fulfill the recommended testing (dilated eye examinations, glycated
hemoglobin, LDL-cholesterol, microalbumin) that had not been performed received in the
preceding year.
Inclusion Criteria:
- Age 18 years or older
- Diabetes, defined as either 1) filled a prescription for insulin or an oral
hypoglycemic agent; or, 2) had two outpatient or one inpatient or two outpatients
encounter claims with an ICD9-CM or CPT code indicating diabetes.
- Gap in a key diabetes management metric as evidenced by no claim for a dilated eye
examination in the prior 15 months and no claim for one or more of the following
tests: glycated hemoglobin, LDL-cholesterol, or microalbumin. (Individuals with
evidence of having received ACE-inhibitors or angiotensin receptor blockers were
considered to have had a microalbumin test.)
Exclusion Criteria:
- No primary care clinician in the data base
- Those who had previously asked the health plan to exclude them from research or
quality improvement
- Women whose claim records contained diagnoses suggesting gestational diabetes
We found this trial at
1
site
Click here to add this to my saved trials